Cargando…

Can Tofacitinib Offer Protection against COVID-19 Infection?

Detalles Bibliográficos
Autores principales:	Goldberger, Tal, Zlotogorski, Abraham
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2021
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089460/ https://www.ncbi.nlm.nih.gov/pubmed/34192119 http://dx.doi.org/10.1159/000514364

Ejemplares similares

BCG-induced trained immunity: can it offer protection against COVID-19?
por: O’Neill, Luke A. J., et al.
Publicado: (2020)

Does wearing masks offer protection against viruses?
por: Donaldson, Alex
Publicado: (2020)

Can vitamin D offer protection against the coronavirus?
por: Wilson, Clare
Publicado: (2020)

Tofacitinib therapy for alopecia areata is not associated with adverse events during COVID-19 infection
por: Youssef, Soundos, et al.
Publicado: (2023)

Tofacitinib is not a biologic
por: Marren, Amy S.
Publicado: (2017)

Tofacitinib reduces mortality in coronavirus disease 2019 Tofacitinib in COVID-19
por: Maslennikov, Roman, et al.
Publicado: (2021)

Tofacitinib Treatment in Patients With Active COVID-19 Infection
por: Alajlan, Abdulmajeed M, et al.
Publicado: (2021)

Treatment of granuloma annulare with tofacitinib
por: Bosch‐Amate, Xavier, et al.
Publicado: (2022)

Targeting chronic COVID-19 lung injury; Tofacitinib can be used against tissue-resident memory T cells
por: Zununi Vahed, Sepideh, et al.
Publicado: (2022)

Micronutrient supplementation before COVID-19 vaccination can protect against adverse effects
por: Dalan, Rinkoo, et al.
Publicado: (2022)

Two Episodes of Simultaneous Identical Alopecia Areata in Identical Twins
por: Lortkipanidze, Nino, et al.
Publicado: (2016)

Use of Tofacitinib in the Context of COVID‐19 Vaccination: Comment on the American College of Rheumatology Clinical Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases
por: Mortezavi, Mahta, et al.
Publicado: (2021)

Waning antibodies from inactivated SARS-CoV-2 vaccination offer protection against infection without antibody-enhanced immunopathology in rhesus macaque pneumonia models
por: Li, Dandan, et al.
Publicado: (2021)

Protecting against COVID-19 aerosol infection during intubation
por: Tseng, Jen-Yu, et al.
Publicado: (2020)

Refractory ulcerations associated with livedoid vasculopathy successfully treated with tofacitinib
por: Jia, Ertao, et al.
Publicado: (2020)

The role and prospect of tofacitinib in patients with ulcerative colitis
por: Lee, Jun
Publicado: (2023)

Mesalazine/tofacitinib/vedolizumab: COVID-19 infection: 3 case reports
Publicado: (2021)

Use of Tofacitinib in the Management of COVID-19 Pneumonia
por: Bande, Balasaheb D
Publicado: (2021)

Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia
por: Guimarães, Patrícia O., et al.
Publicado: (2021)

Travel Times to Facilities Offering Oral Medication Therapy for COVID-19
por: Kahn, Peter A., et al.
Publicado: (2023)

Precautions before starting tofacitinib in persons with rheumatoid arthritis
por: Swarnakar, Raktim, et al.
Publicado: (2022)

Can antipsychotic use protect from COVID-19?
por: Dratcu, Luiz, et al.
Publicado: (2021)

Tofacitinib
Publicado: (2012)

Alopecia Areata and Down Syndrome: A True Association or a Coincidence
por: Ramot, Yuval, et al.
Publicado: (2013)

Rising Violence against Doctors: Can Competency-Based Medical Education through Its Competencies in Palliative Care Offer a Solution?
por: Paul, Sherin Susan, et al.
Publicado: (2020)

Comments on the article “Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study”
por: Thai, Thuy Nhu, et al.
Publicado: (2018)

Efficacy and safety of tofacitinib in patients with polymyalgia rheumatica: a phase 2 study
por: Zhang, Le, et al.
Publicado: (2023)

Subgaleal Drains Offer Protection against Infection in Autologous Cranioplasty, Regardless of Defect Size
por: Spake, Carole, et al.
Publicado: (2021)

Why Do Japanese People Use Masks Against COVID-19, Even Though Masks Are Unlikely to Offer Protection From Infection?
por: Nakayachi, Kazuya, et al.
Publicado: (2020)

A retrospective study of oral tofacitinib therapy for alopecia areata()
por: Lima, Xinaida Taligare Vasconcelos, et al.
Publicado: (2023)

Nanoparticle-based multivalent human antibodies offer potent and broad neutralization against Omicron sublineages
por: Wang, Yizhen, et al.
Publicado: (2023)

Altruism and “love of neighbor” offer neuroanatomical protection against depression
por: Miller, Lisa, et al.
Publicado: (2021)

Decoy Exosomes Offer Protection Against Chemotherapy‐Induced Toxicity
por: Fan, Miao, et al.
Publicado: (2022)

The occurrence of varicella after zoster vaccination in a patient with rheumatoid arthritis receiving tofacitinib
por: KAO, Chung-Mao, et al.
Publicado: (2021)

Antiviral response in vernal keratoconjunctivitis may be protective against COVID‐19
por: Leonardi, Andrea, et al.
Publicado: (2021)

New device and technique to protect intubation operators against COVID-19
por: Chen, Chaojin, et al.
Publicado: (2020)

Offering onsite COVID-19 vaccination to high-risk obstetrical patients: initial findings
por: Hirshberg, Jonathan S., et al.
Publicado: (2021)

Lentiviral and AAV-mediated expression of palivizumab offer protection against Respiratory Syncytial Virus infection
por: Antepowicz, Agata, et al.
Publicado: (2021)

Infliximab and Tofacitinib Attenuate Neutralizing Antibody Responses Against SARS-CoV-2 Ancestral and Omicron Variants in Inflammatory Bowel Disease Patients After 3 Doses of COVID-19 Vaccine
por: Liu, Zhigang, et al.
Publicado: (2023)

Panniculitis as the Transformed Cutaneous Manifestation of Refractory Dermatomyositis with Successful Management with Tofacitinib
por: Rathore, Upendra, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tip74ja4u8u9824vqu19ev5vum